2013 annual financial data
Emergent BioSolutions 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was 31.01%.
Operating income was 42,802,000 USD and net income was 31,135,000 USD.
Operating cash flow was 96,968,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 312,745,000 USD
- Operating income
- 42,802,000 USD
- Net income
- 31,135,000 USD
- Operating cash flow
- 96,968,000 USD